F-group (family)
212.1.1.15 LpxC
Ligands and drugs
477
Member domains
178
with ligand contacts (≤ 4 Å)
37.3% of members
176
with DrugDomain annotations
36.9% of members
112
with a DrugBank compound
23.5% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 212.1.1.15 belongs to X-group 212 Ribosomal protein S5 domain 2-like, which binds 9.4 ligand superclasses per 20 proteins, broader than 86% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03796 | PLM | Palmitic Acid | 11 |
| DB08231 | MYR | Myristic acid | 11 |
| DB04257 | PAM | Palmitoleic Acid | 8 |
| DB01991 | TUX | TU-514 | 6 |
| DB03435 | UDP | Uridine-5'-Diphosphate | 6 |
| DB07536 | C90 | N-{(1S,2R)-2-hydroxy-1-[(hydroxyamino)carbonyl]propyl}-4-{[4-(morpholin-4-ylmethyl)phenyl]ethynyl}benzamide | 6 |
| DB03434 | MPO | 3-(N-morpholino)propanesulfonic acid | 4 |
| DB07355 | AI7 | 3-(heptyloxy)benzoic acid | 4 |
| DB07861 | GVR | (2R)-N-hydroxy-3-naphthalen-2-yl-2-[(naphthalen-2-ylsulfonyl)amino]propanamide | 4 |
| DB00536 | GAI | Guanidine | 1 |
| DB02693 | D1D | (4S,5S)-1,2-dithiane-4,5-diol | 1 |
| DB14212 | MPB | Methylparaben | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| ZNmetal | ZINC ION | 171 |
| CL | CHLORIDE ION | 40 |
| MYR | MYRISTIC ACID | 11 |
| PLM | PALMITIC ACID | 11 |
| 24G | uridine-5'-diphosphate-3-O-(R-3-hydroxymyristoyl)-glucosamine | 10 |
| 3P3 | N-[(1S,2R)-2-hydroxy-1-(hydroxycarbamoyl)propyl]-4-(4-phenylbuta-1,3-diyn-1-yl)benzamide | 8 |
| PAM | PALMITOLEIC ACID | 8 |
| C90 | N-{(1S,2R)-2-hydroxy-1-[(hydroxyamino)carbonyl]propyl}-4-{[4-(morpholin-4-ylmethyl)phenyl]ethynyl}benzamide | 6 |
| TUX | 1,5-ANHYDRO-2-C-(CARBOXYMETHYL-N-HYDROXYAMIDE)-2-DEOXY-3-O-MYRISTOYL-D-GLUCITOL | 6 |
| UDP | URIDINE-5'-DIPHOSPHATE | 6 |
| MGmetal | MAGNESIUM ION | 5 |
| UKW | 4-ethynyl-N-[(1S,2R)-2-hydroxy-1-(oxocarbamoyl)propyl]benzamide | 5 |
| ZH2 | 4-[4-(4-aminophenyl)buta-1,3-diyn-1-yl]-N-[(2S,3R)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]benzamide | 5 |
| 5EP | N~2~-{4-[4-(4-aminophenyl)buta-1,3-diyn-1-yl]benzoyl}-N-hydroxy-L-isoleucinamide | 4 |
| AI7 | 3-(heptyloxy)benzoic acid | 4 |
| FXX | (3R)-3-azanyl-4-oxidanylidene-4-[[3-(trifluoromethyloxy)phenyl]amino]butanoic acid | 4 |
| GVR | (2R)-N-hydroxy-3-naphthalen-2-yl-2-[(naphthalen-2-ylsulfonyl)amino]propanamide | 4 |
| L52 | N-[(2S)-3-amino-1-(hydroxyamino)-1-oxopropan-2-yl]-4-(4-phenylbuta-1,3-diyn-1-yl)benzamide | 4 |
| L58 | 4'-bromo-N-[(2S,3R)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]biphenyl-4-carboxamide | 4 |
| L59 | N-[(2S,3R)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-4-(phenylethynyl)benzamide | 4 |